How should HIV self-testing services be provided?

Pitchaya Indravudh at CROI 2017. Photo credit: Robb Cohen Photography & Video.
Roger Pebody
Published: 17 February 2017

Chairing a session on HIV self-testing at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle this week, Joanne Stekler said that much is already known about the subject – that self-testing is acceptable to a broad range of people, has good uptake with people who have never tested before and can identify new cases, but that the longer window period means that self-testing is a less sensitive method for populations with a high incidence of HIV.

However, there are many things we do not know yet, she said. It’s unclear what impact HIV self-testing will have on the time that elapses between infection and diagnosis, and on the course of the epidemic more broadly. We do not know the best way to implement self-testing, how to reach people who would not otherwise test, how to link testers to HIV medical care or pre-exposure prophylaxis (PrEP), and how to support STI testing alongside HIV self-testing.

Some of the research she introduced began to answer some of these questions, with examples from Malawi and the United States.

Malawi

In order to inform the design of HIV-testing services in Malawi, Pitchaya Indravudh and colleagues used discrete choice experiments to determine the strength of user preferences for different aspects of service delivery and linkage to care.

A discrete choice experiment requires respondents to state their preferences when presented with alternative but hypothetical services. Each alternative is described by several attributes; the responses are analysed to determine which attributes significantly influence people’s choices. Discrete choice experiments can help inform the design of new services.

The discrete choice experiments were nested within household surveys administered to 1258 people in Malawi. Participants had all seen a demonstration of an OraQuick test being used.

Home delivery was preferred to distribution through health facilities or mobile clinics, especially in people who had never tested for HIV before. There were stronger preferences for lay volunteers as providers of tests, rather than health care workers or intimate partners. Even a price as low as US$0.10 would be a disincentive, but less so for men and those who had never tested.

Participants tended to be indifferent about different forms of pre-test support, but disliked instruction leaflets being the only form of support after testing. People who had never tested wanted more extensive support, for example a hotline and the possibility of face-to-face support.

Asked about how a person with a reactive result should link to care, participants preferred to be able to do so at home or in the home of a health care worker, rather than in a health facility or a mobile clinic. Having a shorter waiting time (less than 30 minutes) and a separate waiting room for HIV services would be preferable.

The Malawi researchers also investigated whether the instruction leaflet provided by the manufacturer of the OraQuick ADVANCE® Rapid HIV-1/2 test kits for self-testing use is readily understood by individuals in Malawi. The materials need to be appropriate for rural and low-literacy populations. Although the instructions are largely pictorial, some specific parts of the testing process were not understood or well-performed by all participants. Further, some supposedly universal symbols (such as a knife and fork to symbolise eating) were not recognised by all.

Following this, the researchers ran a feasibility study, in which a brief demonstration of the self-test kit was provided prior to its distribution. Self-testing was reported to be very easy by 95% of participants, with 289 of 291 individuals getting an accurate result. It seems that the demonstration made a substantial difference to the ability of participants to perform the self-test and interpret the results, while allowing them to maintain autonomy in the testing process.

United States

The conference also heard details of the New York City Department of Health and Mental Hygiene’s “giveaway” of self-testing kits to gay men, bisexual men and transgender people who have sex with men. Participants saw advertising on dating apps and websites and completed a brief eligibility assessment. Three-quarters of those screened were eligible and were given a discount code to be used on the test kit manufacturer’s website which allowed them to receive a kit free of charge.

The entire process was conducted online. It took 23 days for the 2500 available codes to be allocated, with 71% of those who got a code redeeming it. A follow-up survey two months later suggested that 80% who received a test used it, most often within a week of receipt.

The programme reached a diverse range of participants (including substantial numbers of younger, low-income and non-white men), 86% of whom were assessed to have a risk of HIV exposure in the previous six months. Nonetheless, the proportion with a reactive (potentially positive) result was low, at 0.6%.

Substantial numbers of men who had never tested for HIV before (14%) or had not done so in the past year (28%) were reached.

Further giveaways have been conducted since this one, with the evaluation findings being used to fine-tune the intervention.

Another group of American researchers are considering how best to provide post-test support, noting that the telephone hotlines typically provided are rarely used. Those in the intervention arm of their pilot study receive self-test kits in the mail every three months.

The kits have been fitted with sensors that enable remote detection of when the kit is opened. HIV test counsellors telephone participants within 24 hours of the test kit being used, in order to conduct counselling, offer referrals to other services, and connect those with reactive results with follow-up care. Early results suggest those receiving these modified test kits are more likely to get risk counselling and be referred to PrEP services.

References

Indravudh P et al. Informing HIV self-testing services in Malawi using discrete choice experiments. Conference on Retroviruses and Opportunistic Infections (CROI 2017), Seattle, abstract 895, 2017.

View the abstract on the conference website.

View a webcast of this presentation on the conference website.

Indravudh P et al. Providing user support for HIV self-testing beyond instructions-for-use in Malawi. Conference on Retroviruses and Opportunistic Infections (CROI 2017), Seattle, abstract 896, 2017.

View the abstract on the conference website.

View a webcast of this presentation on the conference website.

Edelstein Z et al. Feasibility and Reach of a HIV Self-Test (HIVST) Giveaway, New York City, 2015-16. Conference on Retroviruses and Opportunistic Infections (CROI 2017), Seattle, abstract 898, 2017.

View the abstract on the conference website.

Wray TB et al. eTEST: A “smart” home HIV testing system enabling real-time follow-up after testing. Conference on Retroviruses and Opportunistic Infections (CROI 2017), Seattle, abstract 892, 2017.

View the abstract on the conference website.

E-atlas

Malawi

Find details of HIV services in Malawi, the latest news from the country, and a selection of resources from local organisations.

Find out more about Malawi >

E-atlas

United States

Find details of HIV services in United States, the latest news from the country, and a selection of resources from local organisations.

Find out more about United States >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.